PF-4191834 is an Orally Active Inhibitor of the 5-Lipoxygenase
The 5-lipoxygenase (LOX) pathway plays an important role in the pathophysiology of asthma. 5-LOX is an important arachidonic acid-metabolizing enzyme producing leukotrienes and other proinflammatory lipid mediators. Moreover, it has…